Literature DB >> 21401389

Activities of antioxidant enzymes in relation to oxidative and nitrosative challenges in childhood asthma.

Elisabeth Fabian1, Peter Pölöskey, Lajos Kósa, Ibrahim Elmadfa, Lajos Attila Réthy.   

Abstract

BACKGROUND: This study aimed to investigate the relationship between antioxidant enzyme activities, extent of airway inflammation, and systemic oxidative stress in children suffering from atopic asthma.
METHODS: A total of 35 asthmatic (AG) and 21 healthy children (CG) participated in this study. The volume of fractionated exhaled NO (Fe(no)) was measured with the NIOX test system. The activities of the erythrocyte antioxidant enzymes superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GSH-Px), and the total antioxidant capacity (TAC) were determined photometrically. Plasma interleukin (IL)-6 was measured using ELISA; malondialdehyde (MDA) levels were analyzed using HPLC.
RESULTS: Compared to healthy controls, asthmatic children exhaled a significantly (p < .001) higher mean volume of Fe(no), had significantly reduced plasma concentrations of TAC (p = .006), and significantly enhanced levels of MDA (p < .001) and IL-6 (p = .012). SOD (p = .027), CAT (p < .001), and GSH-Px (p = .005) were significantly less active in the asthma group and significantly negatively associated with Fe(no) (SOD/Fe(no): p = .017; CAT/Fe(no): p = .008; GSH-Px/Fe(no): p = .001); the oxidative stress marker MDA showed such correlations in both investigated groups (SOD/MDA: AG: p = .001, CG: p = .381; CAT/MDA: AG: p = .003, CG: p = .020; GSH-Px/MDA: AG: p = .006, CG: p = .011). Furthermore, there was a significant (p< .01) positive correlation between MDA/Fe(no) and MDA/IL-6 observed in both groups.
CONCLUSIONS: These results indicate that inflammation of the bronchial tree, reflected by increased NO formation in the airways and enhanced systemic oxidative stress, is related to an alteration of antioxidant enzyme activities in childhood asthma. Modulating the activity of antioxidant enzymes may therefore have beneficial effects on pulmonary and systemic antioxidant defense mechanisms and could reduce airway inflammation and oxidative stress in asthmatics.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21401389     DOI: 10.3109/02770903.2011.560319

Source DB:  PubMed          Journal:  J Asthma        ISSN: 0277-0903            Impact factor:   2.515


  6 in total

Review 1.  Glutathione redox control of asthma: from molecular mechanisms to therapeutic opportunities.

Authors:  Anne M Fitzpatrick; Dean P Jones; Lou Ann S Brown
Journal:  Antioxid Redox Signal       Date:  2012-03-09       Impact factor: 8.401

2.  New risk factors for adult-onset incident asthma. A nested case-control study of host antioxidant defense.

Authors:  Emma K Larkin; Yu-Tang Gao; Tebeb Gebretsadik; Terryl J Hartman; Pingsheng Wu; Wanqing Wen; Gong Yang; Chunxue Bai; Meiling Jin; L Jackson Roberts; Myron Gross; Xiao O Shu; Tina V Hartert
Journal:  Am J Respir Crit Care Med       Date:  2015-01-01       Impact factor: 21.405

3.  Nutritional supplements and plasma antioxidants in childhood asthma.

Authors:  Elisabeth Fabian; Peter Pölöskey; Lajos Kósa; Ibrahim Elmadfa; Lajos Attila Réthy
Journal:  Wien Klin Wochenschr       Date:  2013-05-01       Impact factor: 1.704

4.  Aldose reductase deficiency in mice protects from ragweed pollen extract (RWE)-induced allergic asthma.

Authors:  Umesh C S Yadav; Leopoldo Aguilera-Aguirre; Istvan Boldogh; Kota V Ramana; Satish K Srivastava
Journal:  Respir Res       Date:  2011-11-03

5.  Combined therapy of iron chelator and antioxidant completely restores brain dysfunction induced by iron toxicity.

Authors:  Jirapas Sripetchwandee; Noppamas Pipatpiboon; Nipon Chattipakorn; Siriporn Chattipakorn
Journal:  PLoS One       Date:  2014-01-06       Impact factor: 3.240

6.  Antioxidant and anti-inflammatory effects of Schisandra and Paeonia extracts in the treatment of asthma.

Authors:  Xia Chen; Yi Huang; Jing Feng; Xiao-Fang Jiang; Wan-Fei Xiao; Xiao-Xi Chen
Journal:  Exp Ther Med       Date:  2014-09-04       Impact factor: 2.447

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.